Skip to main content

Table 1 Demographics and clinical data of 18 patients with S. arizonae infections in our case series

From: Salmonella enterica subspecies arizonae infection of adult patients in Southern Taiwan: a case series in a non-endemic area and literature review

Age by years (median, range) 63.5 (27–81)
Male to female ratio 12 : 6
Underlying diseases (No., %)
 Diabetes mellitus 10 (55.6)
 Hypothyroidism 2 (11.1)
 Peptic ulcer diseases 8 (44.4)
 Hepatocellular carcinoma 4 (22.2)
 Lung cancer 3 (16.7)
 Colon cancer 1 (5.6)
 Multiple myeloma 1 (5.6)
 Hypertension 7 (38.9)
 Liver cirrohosis 6 (33.3)
 Hepatitis B 5 (27.8)
 Hepatitis C 2 (11.1)
 Chronic kidney diseases 3 (16.7)
 Systemic lupus erythematosus 1 (5.6)
 AIDS 1 (5.6)
Symptoms (No., %)
 Fever 9 (50.0)
 Abdominal discomfort 7 (38.9)
 Dyspnea 7 (38.9)
Laboratory data (No., %)
 WBC > 10000/μl 10 (55.6)
 CRP > 10 mg/dL 8/17 (47.1)
 ALT > 44 U/L 8/17 (47.1)
 Creatinine > 1.3 mg/dl 7/17 (41.2)
Site of bacterial isolation (No., %)
 Blood 10 (55.6)
 Bone 2 (11.1)
 Abscess 2 (11.1)
 Pleural effusion 2 (11.1)
 Sputum 1 (5.6)
 Stool 1 (5.6)
 Ascites 1 (5.6)
 Urine 1 (5.6)
Clinical presentations (No., %)
 Lower respiratory tract infection 4 (22.2)
 Bone and joint infection 3 (16.7)
 Gastrointestinal tract infection 3 (16.7)
 Intra-abdominal infection/peritonitis 3 (16.7)
 Soft tissue infection 2 (11.1)
 Mycotic aneurysm 2 (11.1)
 Urinary tract infection 1 (5.6)
Definite antibiotic treatment (No., %)
 3rd generation cephalosporins 13 (72.2)
 Fluoroquinolones 3 (16.7)
 Piperacillin/tazobactam 1 (5.6)
 TMP/SMX 1 (5.6)
Intensive care unit stay (No., %) 9 (50.0)
Length of hospitalization, days (mean ± standard deviation) 19.7 ± 13.7
In-hospital mortality (No., %) 1 (5.6)
  1. AIDS acquired immunodeficiency syndrome, WBC white blood cell, CRP C-reactive protein, ALT alanine aminotransferase, TMP/SM trimethoprim/sulfamethoxazole